REAL-WORLD TREATMENT PATTERNS AND COSTS OF CARE AMONG BRENTUXIMAB VENDOTIN-TREATED PATIENTS WITH HODGKIN LYMPHOMA IN THE UNITED STATES

Author(s)

Szabo SM¹, Hirji I², Johnston KM¹, Juarez-Garcia A³, Subar M², Connors JM⁴
¹Broad Street Health Economics & Outcomes Research, Vancouver, BC, Canada, ²Bristol-Myers Squibb, Princeton, NJ, USA, ³Bristol-Myers Squibb Company, Ciudad de México, Mexico, ⁴British Columbia Cancer Agency Centre for Lymphoid Cancer (BCCA CLC), Vancouver, BC, Canada

Presentation Documents

PCN108--strong-u-szabo-sm-u-sup-1-sup-strong-hirji-i-sup-2-sup-johnston-km-sup-1-sup-juarez-garcia-a-sup-3-sup-subar-m-sup-2-sup-connors-jm-sup-4-sup-br-sup-1-sup-broad-street-health-economics-outcomes-research-vancouver-bc-canada-sup-2-sup ...

OBJECTIVES:

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PCN108

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Oncology

Explore Related HEOR by Topic

Economic Evaluation

Presentation